uncomplicated gonorrhea epidemiology forecast

Uncomplicated Gonorrhea Insights and Trends

• According to DelveInsight’s estimates, the total incident cases of Uncomplicated Gonorrhea in the US were approximately 401,240 in 2025.
• Gonorrhea continues to be a significant public health concern worldwide, and the growing challenge of antimicrobial resistance only heightens the urgency for new treatment options. Gonorrhea affects more than 82 million people worldwide annually. In the United States, it is the second most reported bacterial sexually transmitted infection (STI). While approximately 600,000 cases are reported annually in the US.
• Gonorrhea is diagnosed more often in men, as symptoms prompt earlier care, while infections in women are frequently asymptomatic, leading to underdiagnosis, delayed treatment, and increased risk of complications and ongoing transmission.
• In the US, most new gonorrhea infections are uncomplicated and involve the urogenital, anogenital, or pharyngeal regions.Complicated infections resulting in bacteremia, septic arthritis, endocarditis, or meningitis are less common.

Uncomplicated Gonorrhea Epidemiology Forecast in the United States

• 2025 Incident Cases of Uncomplicated Gonorrhea: ~401,240
• Uncomplicated Gonorrhea Growth Rate (2026–2036): -2.3 CAGR

DelveInsight's ‘Uncomplicated Gonorrhea – Epidemiology Forecast – 2036’ report delivers an in-depth understanding of the Uncomplicated Gonorrhea, historical and forecasted epidemiology in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Uncomplicated Gonorrhea  Understanding and Diagnosis Algorithm

Uncomplicated Gonorrhea Overview

Uncomplicated Gonorrhea is a common sexually transmitted infection (STI) caused by the bacterium Neisseria gonorrhoeae, characterized by localized infection of mucosal surfaces such as the urethra, cervix, rectum, oropharynx, and conjunctiva. The disease typically presents with symptoms including urethral or vaginal discharge, dysuria, and genital irritation, although many infections particularly in women may be asymptomatic. Uncomplicated gonorrhea refers to infection confined to these mucosal sites without systemic dissemination or complications such as pelvic inflammatory disease or disseminated gonococcal infection. If untreated, the infection can lead to reproductive tract complications, infertility, and increased risk of HIV transmission, while growing antimicrobial resistance has become a major challenge in disease management worldwide.

Uncomplicated Gonorrhea Diagnosis

The approach to diagnostic testing for N. gonorrhoeae has evolved from traditional cultivation to the widespread use of Nucleic Acid Amplification Tests (NAATs). Gram stain, another non-culture test, can be used if available for the diagnosis of urethral gonorrhea in symptomatic males. Culture is still recommended if antimicrobial resistance is a concern, especially in cases of suspected treatment failure. Routine screening for gonococcal infection in persons at increased risk is recommended in order to decrease morbidity and reduce the burden of disease in the community. Testing samples should be obtained from the anatomic sites of sexual exposure.

Further details are provided in the report.

Uncomplicated Gonorrhea Epidemiology

Key Findings from Uncomplicated Gonorrhea Epidemiological Analysis and Forecast

• According to DelveInsight’s estimates, the total incident cases of Gonorrhea in the US were approximately 401,240 in 2025.
• In 2025, among total cases of Uncomplicated Gonorrhea in the US is the most incident type (~401,240 cases), compared to Complicated Gonorrhea~84,300.
• The total number of Male Uncomplicated Gonorrhea patients was found to be more ~242,840 as compared to Female patients ~158,400  in 2025.
• Men are diagnosed with gonorrhea more often than women, as their symptoms are typically more evident and lead to earlier care-seeking. The infection predominantly affects adolescents and young adults, particularly those aged 15–24 years.

Scope of the Report

• The report covers a segment of an executive summary, a descriptive overview of Uncomplicated Gonorrhea, explaining its causes, signs and symptoms, and pathogenesis.
• Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of the diagnosis rate, and disease progression.

Report Insights

• Uncomplicated Gonorrhea patient population forecast

Report Key Strengths

• Epidemiology-based (epi-based) bottom-up forecasting
• 11-year forecast
• Patient burden trends (by geography)

FAQs

• What are the disease risks, burdens, and unmet needs of Uncomplicated Gonorrhea? What will be the growth opportunities across the 7MM concerning the patient population with Uncomplicated Gonorrhea?
• What is the historical and forecasted Uncomplicated Gonorrhea patient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?

Reasons to Buy

• Insights on patient burden/disease prevalence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
• To understand key opinion leaders’ perspectives around the diagnostic challenges to overcome barriers in the future.
• Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.